NHS
Science & DTx
For business
Solutions
Clinicians
Investors
About us
Contact us
FacebookTwitterLinkedinYouTube
News
2 Min Read

Dr Andy Blackwell speaks to pharmaphorum about ieso’s latest study conducted with support from Roche Diabetes Ltd

02 Aug 2022
By
ieso

ieso’s Group Chief Science and Strategy Officer, Dr Andy Blackwell recently featured in pharmaphorum's article “Beyond the pill in an outcome-based world”.

It examines how pharmaceutical-led patient support programmes can be supplemented and supported by additional healthcare interventions, particularly mental health support. Andy explained to her how our recent study, conducted with support from Roche Diabetes Care Limited, found that tailored, online cognitive behavioural therapy (CBT) can not only improve mental health outcomes for diabetes patients, but can also boost quality of life, reduce diabetes distress, and, crucially, improve self-management of their condition.

Read the full article here. If you’d like to read more about our further scientific research, click here.

About pharmaphorum:

pharmaphorum combines industry-leading publications, strategic consulting and a content-driven stakeholder engagement agency. pharmaphorum.com, and its associated digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate.

ieso
ieso’s Group Chief Science and Strategy Officer, Dr Andy Blackwell features in pharmaphorum's article “Beyond the pill in an outcome-based world”
News
24 Nov 2022

Watch our Director of Mental Health Sciences Dr Louise Marshall’s presentation at MQ Mental Health Research Mental Health Science Festival 2022

News
3 Min Read
21 Nov 2022

ieso has been selected as the Most Transformative Digital Healthcare Company at the 2022 OBN Awards, held at the Royal Lancaster in London.

News
2 Min Read
16 Nov 2022

ieso’s Chief AI Officer, Dr Valentin Tablan was featured in IEEE Pulse magazine’s recent article on how AI is being used to improve mental health treatment